- Home
- NRXP vs KPLT Comparison
NRXP vs KPLT Comparison
Compare NRXP & KPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- KPLT
- Stock Information
- Founded
- NRXP 2015
- KPLT 2012
- Country
- NRXP United States
- KPLT United States
- Employees
- NRXP N/A
- KPLT N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- KPLT Diversified Commercial Services
- Sector
- NRXP Health Care
- KPLT Consumer Discretionary
- Exchange
- NRXP Nasdaq
- KPLT Nasdaq
- Market Cap
- NRXP 32.6M
- KPLT 34.5M
- IPO Year
- NRXP N/A
- KPLT N/A
- Fundamental
- Price
- NRXP $3.02
- KPLT $10.92
- Analyst Decision
- NRXP Strong Buy
- KPLT Hold
- Analyst Count
- NRXP 4
- KPLT 2
- Target Price
- NRXP $28.50
- KPLT $12.00
- AVG Volume (30 Days)
- NRXP 187.5K
- KPLT 23.7K
- Earning Date
- NRXP 08-13-2025
- KPLT 08-13-2025
- Dividend Yield
- NRXP N/A
- KPLT N/A
- EPS Growth
- NRXP N/A
- KPLT N/A
- EPS
- NRXP N/A
- KPLT N/A
- Revenue
- NRXP N/A
- KPLT $254,079,000.00
- Revenue This Year
- NRXP N/A
- KPLT $22.26
- Revenue Next Year
- NRXP N/A
- KPLT $11.03
- P/E Ratio
- NRXP N/A
- KPLT N/A
- Revenue Growth
- NRXP N/A
- KPLT 9.72
- 52 Week Low
- NRXP $1.10
- KPLT $5.08
- 52 Week High
- NRXP $6.01
- KPLT $21.88
- Technical
- Relative Strength Index (RSI)
- NRXP 43.71
- KPLT 63.37
- Support Level
- NRXP $2.89
- KPLT $9.29
- Resistance Level
- NRXP $3.53
- KPLT $10.01
- Average True Range (ATR)
- NRXP 0.15
- KPLT 0.62
- MACD
- NRXP -0.06
- KPLT 0.17
- Stochastic Oscillator
- NRXP 18.97
- KPLT 81.21
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About KPLT Katapult Holdings Inc.
Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.